Sandoz AG moves to get out of US states' antitrust case over generic drugs
MLex Summary: Sandoz AG moved to dismiss amended US antitrust claims filed by US states in a case over generic drug pricing, arguing that they lack jurisdiction. “The court need not,...To view the full article, register now.
Already a subscriber? Click here to view full article